The purpose of this study is to provide patients who have relapsed or refractory Mantle Cell Lymphoma (MCL) with early access to an investigational medication called ibrutinib (PCI-32765) and to collect safety information about the drug.
Drug: Ibrutinib
Ibrutinib
Inclusion Criteria:
- Patients, 18 years of age and older, with Mantle Cell Lymphoma who have relapsed or
refractory disease after prior therapy are eligible.
Exclusion Criteria:
- Patients eligible for enrollment in any other ongoing clinical study of ibrutinib are
not eligible.
- Patients previously treated with ibrutinib are not eligible.
- Patients enrolled in another interventional clinical study with therapeutic intent are
not eligible.
Phoenix, Arizona, United States
Duarte, California, United States
La Jolla, California, United States
Los Angeles, California, United States
Stanford, California, United States
Denver, Colorado, United States
Norwalk, Connecticut, United States
Stamford, Connecticut, United States
Washington, District of Columbia, United States
Brandon, Florida, United States
Miami Beach, Florida, United States
Ocala, Florida, United States
Orlando, Florida, United States
Palm Beach Gardens, Florida, United States
Atlanta, Georgia, United States
Chicago, Illinois, United States
Springfield, Illinois, United States
Goshen, Indiana, United States
Sioux City, Iowa, United States
Lexington, Kentucky, United States
Louisville, Kentucky, United States
Metairie, Louisiana, United States
Baltimore, Maryland, United States
Boston, Massachusetts, United States
Worcester, Massachusetts, United States
Ann Arbor, Michigan, United States
Detroit, Michigan, United States
Rochester, Minnesota, United States
Jefferson City, Missouri, United States
Saint Louis, Missouri, United States
Lincoln, Nebraska, United States
Omaha, Nebraska, United States
Reno, Nevada, United States
Hackensack, New Jersey, United States
New Hyde Park, New York, United States
New York, New York, United States
Syracuse, New York, United States
Durham, North Carolina, United States
Cleveland, Ohio, United States
Columbus, Ohio, United States
Hershey, Pennsylvania, United States
Philadelphia, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Watertown, South Dakota, United States
Knoxville, Tennessee, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Dallas, Texas, United States
Houston, Texas, United States
Lubbock, Texas, United States
Burlington, Vermont, United States
Charlottesville, Virginia, United States
Morgantown, West Virginia, United States
Madison, Wisconsin, United States
Barretos, Brazil
Florianopolis, Brazil
Porto Alegre, Brazil
Rio De Janeiro, Brazil
Salvador, Brazil
Sao Paulo, Brazil
San Juan, Puerto Rico